Home  >  Products  >  CHRDL2 (chordin-like 2 ) Blocking Peptide (the N terminal of CHRDL2)(100ug)
CHRDL2 (chordin-like 2 ) Blocking Peptide (the N terminal of CHRDL2)(100ug)

CHRDL2 (chordin-like 2 ) Blocking Peptide (the N terminal of CHRDL2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CHRDL2 Antibody (ARP66005_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP66005
Size: 100ug
Weight: 3kDa
Gene: 25884
Format: Lyophilized powder
Target: CHRDL2 is implicated in tumor angiogenesis. CHRDL2 may inhibits BMPs activity by blocking their interaction with their receptors. CHRDL2 has a negative regulator effect on the cartilage formation/regeneration from immature mesenchymal cells, by preventing or reducing the rate of matrix accumulation. CHRDL2 may play a role during myoblast and osteoblast differentiation, and maturation.
Alternative names: BNF1; CHL2; DKFZp586N2124; FKSG37
See Full Product Listings >